PNOC High Grade Glioma Informational Webinar

Hear the latest pediatric high grade glioma research and clinical trial updates from PNOC's expert scientific panel.

Donate to support this vital work towards pediatric brain cancer cures: https://www.pnocfoundation.org

Learn more about PNOC's research groups and clinical trial:
https://pnoc.us

FEATURED SPEAKERS:

Dr. Sabine Mueller Pacific Pediatric Neuro-Oncology Consortium (PNOC) Co-founder and Project Lead; Professor of Neurology, Neurosurgery and Pediatrics at University of California, San Francisco (UCSF); Affiliated Professor at the University of Zurich, Switzerland. Dr. Mueller is a pediatric neuro-oncologist who specializes in the care of children with brain tumors. She leads the pediatric brain tumor program at UCSF and serves as one of the leads of the pediatric malignancy program of the UCSF Helen Diller Comprehensive Cancer Center.

Dr. Michael Prados Pacific Pediatric Neuro-Oncology Consortium (PNOC) Co-founder and Co-Project Leader; Charles B. Wilson, MD, Endowed Chair in Neurological Surgery, Professor Emeritus, Department of Neurological Surgery and Department of Pediatrics, UCSF. Dr. Prados has over 35 years' experience at UCSF in treating both adults and children who have brain tumors. His current research interest is translational and clinical research in pediatric neuro-oncology.

Dr. Andrea (Flynn) Franson is a Pediatric Oncologist in the Department of Pediatrics at the University of Michigan. She received her bachelor’s degree from Rensselaer Polytechnic Institute in Troy, New York and her medical degree from the University of Michigan Medical School. She completed her residency in Pediatrics and fellowship in Pediatric Hematology/Oncology at the Children’s Hospital of Philadelphia (CHOP). During fellowship, she earned a master’s degree in Pharmacology from Thomas Jefferson University in Philadelphia. Dr. Franson has focused her research efforts in translational science, working to transition the most promising compounds into the clinic for children with cancer.

Dr. Tom Belle Davidson is a pediatric neuro-oncologist who specializes in caring for children with brain and spine tumors. Her research is focused on developing novel clinical therapies. She is currently developing a clinical trial using immunotherapy to improve the outcomes of children with high-grade gliomas.

Dr. Jasper van der Lugt is a pediatric oncologist, with a focus on high grade pediatric brain tumors. He obtained his Medical Degree at the University of Utrecht and his PhD from the University of Amsterdam. Since 2018 he is appointed at the Princess Maxima Center as a treating physician and lead of the neuro-oncology subdivision of the Trial and Data Center within the Maxima. At this position he is responsible for implementation and development for early phase trials. His research focus is on clinical and translational (cellular) immune therapy for children with a CNS malignancy. He is a member of the independent ethics committee (IEC) of the University Medical Center of Utrecht.

Dr. Elias Sayour is an Assistant Professor of Neurosurgery and Pediatrics and Principal Investigator of the RNA-Engineering Lab at the University of Florida. He functions as the newly appointed Director of the Pediatric Cancer Immunotherapy Initiative (PCI2) of the UF Health Cancer Center and Vice Chair of the UFHCC Scientific Review Monitoring Committee. As a board-certified pediatrician and oncologist, Dr. Sayour has extensive translational experience as PI/Co-I on several human trials. His translational efforts are also focused on new pipeline technologies including a novel lipid-nanoparticle (NP) formulation that he pioneered for the immunologic treatment of cancer currently being tested in canine (pet dog) patients with terminal brain cancer before translation into dedicated human studies.